Moreover, utilizing LLC-SD cells and syngeneic orthotopic lung cancer model that we established and characterized 28, we have revealed that PI3K/AKT pathway enhanced the tumorigenicity by promoting the stemness of lung CSCs, while MAPK/ERK pathway promoted the proliferation and differentiation of lung CSCs to drive oncogenesis. This evidence concerns the gene AKT1 and lung cancer.